Nasdaq

Seqirus Announces Late-Breaking Data at IDWeek 2020: New Real-World Evidence Shows Value of Adjuvanted Influenza Vaccine for Adults 65 Years and Older with Underlying Health ...

SUMMIT, N.J., Oct. 21, 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today announced new, late-breaking real-world evidence (RWE) to be presented at IDWeek 2020 indicating ...
Business Insider

Seqirus Presents New Real-World Evidence on Relative Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Adults 65 Years and Older at IDWeek 2020

SUMMIT, N.J., Oct. 21, 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today presented new real-world evidence (RWE) on the effectiveness of an MF59 ®-adjuvanted, trivalent ...
Nasdaq

New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020

ADELAIDE, Australia, Oct. 26, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that new clinical data has been presented on TOLSURA® (SUBA®-itraconazole) at IDWeek ...
Business Insider

Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020

DUBLIN, Ireland and CHICAGO, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation ...
Medscape

Pharmacists News

IDWeek 2020 Fulminant C diff Debate: Fecal Transplants or Antibiotics? One expert at IDWeek says fecal microbiota transplants should be initiated before colectomy. Another says traditional ...